Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why AbbVie Stock Slumped Today

TheMotleyFool 
0 0 01.08.26
Why AbbVie Stock Slumped Today: https://g.foolcdn.com/editorial/images/881665/medical-professional-assisting-with-a-person-in-an-mri-machine.jpg
 

High-flying pharmaceutical company (NYSE: ABBV) has seen its stock rise in many recent sessions. Yet Friday's wasn't one of them, as the company's shares took a nearly 3% loss on the back of a second-quarter earnings report that investors found uninspiring.

AbbVie unveiled that quarter's figures before market open. Its revenue came in at just under $17 billion for the period, which was more than 10% higher year over year. It also managed to boost its net income not under generally accepted accounting principles (non-GAAP, or adjusted) by 23% to almost $6.5 billion, or $3.65 per share.

Image source: Getty Images.

Continue reading


Source Fool.com

AbbVie Inc. Stock

€217.50
-0.050%
With only a change of -€0.100 (-0.050%) the AbbVie Inc. price is nearly unchanged from yesterday.
The stock is an absolute favorite of our community with 45 Buy predictions and no Sell predictions.
As a result the target price of 230 € shows a slightly positive potential of 5.75% compared to the current price of 217.5 € for AbbVie Inc..
Show more
Like: 0
ABBV
Share

Comments

Not a member yet? Sign up for free!